At its 15th annual meeting, MichBio discussed how the loss of Pfizer
has hurt the state's life sciences industry, but there are many bright
spots on which to focus.
Excerpt:
The past few months have left life-sciences companies feeling like
they’ve been riding the good ride going to lofty places only to have
unthinkable happen, said Stephen Rapundalo, executive director of
MichBio.
Read the entire article
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.